Inside "The Chateau" and How Novel Serves as Microcosm of Trump's America
Author Paul Goldberg is taking on something familiar, and turns it upside down in his novel "The Chateau." The book captures a setting that becomes a microcosm of today's current political landscape. Goldberg explains what he hopes readers takeaway.
"What I wanted to do was look at a corrupt governmental system, a structure that is resistant to any sort of transparency and that is a condo board in Florida," says Goldberg. "What I want to show is how divided we are as a country right now."
Goldberg explores these divisions within a fictional Russian family based in Florida, set one week before President Trump's inauguration.
Intel CEO Lip-Bu Tan says he’s “always operated within the highest legal and ethical standards” after coming under pressure following President Donald Trump’s call for him to resign.
Millions of Americans saving for retirement through 401(k) accounts could have the option of putting their money in higher-risk private equity and cryptocurrency investments.
A new federal rule would make it easier for companies to use drones over longer distances out of sight of the operator without having to go through a cumbersome waiver process.
President Donald Trump has signed the GENIUS Act into law, setting new regulations for stablecoins, a type of cryptocurrency tied to assets like the U.S. dollar.
A top Federal Reserve official said late Thursday that the central bank should cut its key interest rate later this month, carving out a different view than that of Chair Jerome Powell
Stocks fell on Wall Street as the Trump administration stepped up pressure on trading partners to make deals before punishing tariffs imposed by the U.S. take effect.
A stark disagreement over regulating AI in Republicans’ tax cut and spending bill is the latest tension among conservatives about whether to let states continue to put guardrails on emerging technologies or minimize such interference.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
